Cited by 32Regulation of Appetite and ObesityNeuropeptides and Animal PhysiologyDiabetes Treatment and Management

Glucagon-like peptide-1 (GLP-1) action in the mouse area postrema neurons

Kawatani, Masahiro, Yamada, Yuichiro, Kawatani, Masahito·2018·Peptides

Abstract

Glucagon-like peptide-1 (GLP-1) is a peptide hormone and member of the incretin family. GLP-1 related drugs, such as liraglutide, are widely used to treat diabetic patients and work by stimulating pancreatic β cells to increase glucose-dependent insulin secretion. However, extrapancreatic effects, such as appetite suppression or emesis, are observed in response to GLP-1 receptor agonists. In this study we used the in vitro patch-clamp method in acute brainstem preparations of mice and demonstrated that GLP-1 acts directly on area postrema neurons. It is known that activation of the area postrema is related to the induction of homeostatic autonomic nervous systems, including nausea. Approximately,half of the neurons tested in the area postrema were excited by GLP-1 in the presence of tetrodotoxin, and is thought to be through adenylate cyclase-cAMP pathways. Excitation was not frequently observed in nucleus tractus solitaries neurons or in area postrema neurons from GLP-1 receptor knock-out mice. These results indicate that GLP-1 receptor agonists excite area postrema neurons and potentially leading to the expression of extra-pancreatic effects. This is the first study to show that GLP-1 directly activates area postrema neurons.

Integrity signals

Registry

Crossref · 10.1016/j.peptides.2018.07.010

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • An alternative explanation for GI symptoms is direct interaction of GLP-1RAs with GLP-1R in brain regions such as the brainstem (area postrema, nucleus tractus solitarii), which are not protected by the blood-brain barrier and are typically involved in medication-induced nausea.

    “an alternative explanation, albeit not mutually exclusive, is direct interaction of GLP-1RAs with GLP-1R in brain regions such as the brainstem (area postrema, nucleus tractus solitarii), which are not protected by the blood-brain barrier, and are typically involved in medication-induced nausea (chemosensitive area) (54–56).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kawatani, M., Yamada, Y., & Kawatani, M.
Affiliations
Akita University (JP)
Corresponding author
Kawatani, Masahiro
Venue
Peptides
Publisher
Elsevier BV
Published
2018-09
Volume
107
Pages
68-74
ISSN
0196-9781 (ISSN-L)
OpenAlex
W2887194013
Cited by
32
References
51
Citations by year
2026: 4 · 2025: 6 · 2024: 6 · 2023: 1 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 4
FWCI
1.65
Type
journal article
Language
en
Open access
closed
Locations
  • Peptides (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
glucagon-like peptide-1, GLP-1 receptor, GLP-1 receptor agonists, liraglutide, nausea, vomiting, nucleus tractus solitarius, neuronal excitation
MeSH terms
Glucagon-Like Peptide-1 Receptor, Animals, Female, Male, Mice, Inbred C57BL, Neurons, Mice, Knockout, Patch-Clamp Techniques, Area Postrema, Mice, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review